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Abstract. Using a K562 cell transfection model, we 
have previously described a novel relationship between 
the integrins 11v133 and ot5131. %133 ligation was able to in- 
hibit ot5131-mediated  phagocytosis without effect on 
o~5131-mediated adhesion. The 11v133-dependent  inhibi- 
tion apparently required a signal transduction cascade 
as it was reversed by inhibitors of serine/threonine  ki- 
nases. Now, we have studied the mechanisms of signal 
transduction in this system and have found that the 133 
cytoplasmic tail is both necessary and sufficient for ini- 
tiation of the signal leading to inhibition of a5131 phago- 
cytosis. Ligation of integrin-associated protein (IAP), 
which has been implicated in 11v133 signal transduction, 
mimics the effects of 11v133 ligation only when the 133 in- 
tegrin with an intact cytoplasmic tail is present. Al- 
though fibronectin-mediated  phagocytosis requires the 
high affinity conformation of 115131, ligation of Otv133/IAP 
does not prevent acquisition of this high affinity state. 
We conclude that CXv133/IAP  ligation initates a signal 
transduction cascade, dependent upon the 133 cytoplas- 
mic tail, which inhibits the phagocytic function of eL5131 
at a step subsequent to modulation of integrin affinity. 
I 
NTEGRIN functions are modulated in many cells. This is 
best understood in the regulation of leukocyte adhe- 
sion and in platelet activation (9, 16, 24, 37). In these 
cell  types,  integrins  have  at  least  two  conformational 
states.  One,  exhibiting  a  low  affinity  for  ligand,  is  ex- 
pressed by unactivated cells. The second state, which has a 
much higher affinity for ligand, is expressed by cells after 
activation.  The  signals  which initiate  the  transition  from 
low to high affinity states include thrombin and ADP stim- 
ulation in platelets (17, 19, 37), and a variety of serpentine 
receptor ligands in leukocytes, including the bacterial pep- 
tide f-Met-Leu-Phe,  the complement  activation  fragment 
C5a, the product of arachidonate  metabolism LTB4, and 
chemokines such as MCP-1 (7, 16, 20, 27, 36). 
In leukocytes, integrin function also can be regulated by 
ligation of another integrin. For example, 115131 ligation ac- 
tivates 112131 collagen binding in monocytes (39).  133 inte- 
grins can influence the function of other receptors as well. 
Adhesion  and  activation  studies  suggest  the  hypothesis 
that on phagocytes, the ligation of B3 integrins  may be an 
early event in inflammation, directly affecting the function 
of other proinflammatory receptors (21, 42, 49). For exam- 
ple, 133 integrin ligation activates the ability of the 132 inte- 
grin  Mac-1  to  bind  its  ligands  in  both  neutrophils  and 
monocytes  (26, 44).  This  133-initiated  signal  transduction 
requires a second plasma membrane protein, a member of 
the  immunoglobulin  superfamily  with  five  membrane- 
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spanning  domains,  known  as  integrin-associated  protein 
(IAP) 1 (32, 49). The molecular mechanism(s)  involved in 
regulation of leukocyte integrin function by 133/IAP are in- 
completely understood. 
Recently, we have developed a model in which to study 
the mechanism  of 133 "crosstalk"  with other integrins.  In 
K562 cells transfected with 11v[33, ligation  of this integrin 
inhibits the phagocytic function of the integrin fibronectin 
receptor,  115131, which is endogenously expressed in K562 
(2). This effect requires signal transduction, since it can be 
reversed by the serine/threonine  kinase inhibitor  H7 and 
the more specific protein kinase C inhibitor Calphostin C. 
Surprisingly, 11v[33  ligation affects phagocytosis without af- 
fecting the adhesive functions of 115131, suggesting that the 
signal  transduction  discretely  inhibits  high  affinity  115131 
function  (phagocytosis)  without  altering  the  low affinity 
receptor function (adhesion) (18). 
We now have used this model to dissect the roles of the 
integrin 11 and 13 chains and IAP in initiation of the signal 
transduction cascade. We show that tXlib133 is as effective as 
11v133 for initiation  of this signal.  Deletion of the 133 cyto- 
plasmic  tail  prevents  signaling,  while  expression  of  a 
chimeric molecule consisting of the IL2 receptor 11 chain 
extracellular and transmembrane domains and the 133 cyto- 
plasmic tail constitutively prevents 115131  phagocytosis. This 
probably represents  continuous  signal  transduction  from 
the autonomous  ~3 cytoplasmic domain rather than corn- 
1. Abbreviations used in this paper." Fg, fibrinogen; Fn, fibronectin; IAP, 
integin-associated protein; LPA, lysophosphatidic acid; PI, phagocytic in- 
dex; Vn, vitronectin. 
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because inhibition of phagocytosis is rapidly reversed by 
H7, and because the chimera has no effect on ct5131 medi- 
ated adhesion to fibronectin (Fn)-coated surfaces. These 
data show that the 133 cytoplasmic tail is  both necessary 
and sufficient for initiation of the signal transduction cas- 
cade. IAP ligation only inhibits et5131 phagocytosis when 
Otv133 is expressed, and, surprisingly, anti-IAP loses its in- 
hibitory effect in cells expressing 133 without its cytoplas- 
mic tail. Finally, neither constitutive nor ligand-dependent 
[33-initiated signal transduction affect the number of a5131 
expressing the high affinity conformation. From these data, 
we hypothesize that ligation of the Ctv133/IAP complex ini- 
tiates a signal transduction cascade mediated by the 133 cy- 
toplasmic tail which affects et5131 function at a step beyond 
regulation of integrin conformation. 
Materials and Methods 
Ce//s 
The human erythroleukemia cell line K562  was maintained in Iscove's 
Modified Dulbecco's Medium (GIBCO, Gaithersburg, MD), containing 
10% FBS (Hycloue, Logan, UT) and 1.0 ~g/ml Gentamicin (Sigma Chem. 
Co., St. Louis, MO) and propagated in a 37°C, 5% CO2, humidified incu- 
bator. 
Truncation of the f13 Integrin Subunit 
The integrin [39 subunit cytoplasmic domain was truncated at residue 728 
by PCR mutagenesis to permit direct comparisons with previous work by 
other authors (11, 38).  A  2,640-bp fragment of the [33 cDNA subcloned 
into pRc/RSV (termed pIAP93) (2) was purified by restriction with AflII 
and HindIII and used as a PCR template. To terminate coding at residue 
728 and introduce a novel SpeI restriction site the mutant oligonucleotide 
(5'-ATC CTG GTG TAA GAC TAG TCA GTG -3', bases 2171-2194) 
and its reverse complement were used in two separate PCR reactions with 
oligonucleotides exactly matching either a 5' upstream sequence overlap- 
ping and encoding the AfllI restriction site (5'-GAA AGA GCT TAA 
GGA  CAC TGG  CAA-3', bases 2020-2044);  or  a  3'  downstream se- 
quence overlapping and encoding the HindlII restriction site (5'-GCC 
CAA GCT TTA GCT ATT CGA ACG -3', bases 4640-4663).  The two 
PCR products resulting from these reactions were subjected to restriction 
with AflII/SpeI and SpeI/HindIII, respectively. These products were puri- 
fied and ligated back into the AflII/HindIII digested and purified plAP93 
restoring all 3' untranslated sequence from the original construct resulting 
in a cDNA encoding a 133 protein which terminates after amino acid 728, 
which we named 133NT. 
Protein Purifications 
Fibronectin and fibrinogen were provided by Dr. John E. Kaplan, Albany 
Medical College (Albany, NY) and prepared as described (3). Vitronectin 
was prepared as described (48)  by denaturation and adsorption on hep- 
arin. Casein was purchased in solution from Pierce (Rockford, IL). Purity 
of all protein reagents was determined to be greater than 99%  by SDS- 
PAGE. 
Antibodies 
Polyclonal antibody against human Ctv133 and  a~135 integrins were pur- 
chased from GIBCO BRL. The a~13s-specific  monoclonal antibody (mAb) 
P1F6 (45) was the gift of Dr. Dean Sheppard (UCSF, San Francisco, CA). 
The  ctv133-reactive mAb LM609  (12)  was  a  gift of Dr.  David  Cheresh 
(Scripps Research Institute, La Jolla, CA).  The mAb BIIG2 and AIIB2, 
reactive with human integrin subunits a5  and  131, respectively (22,  46), 
were the kind gift of Dr. Caroline Damsky (UCSF, San Francisco, CA), 
The human integrin as-reactive mAb 16 (14) was the gift of Dr. Kenneth 
Yamada (NIDH/NIH, Rockville, MD). mAb IB4 (47) was the gift of Dr. 
Sam Wright (Rockefeller University, New York, NY). The 131 integrin ac- 
tivating antibodies A1A5 (23) and 8A2 (28) were generously provided by 
Dr. Martin Hemler (Dana-Farber Cancer Institute, Boston, MA) and Drs. 
Nick Kovach and John Harlan (University of Washington, Seattle, WA), 
respectively. The  anb133 specific monoclonal antibodies  10E5  and  7E3 
were the gift of Dr. Barry Coller (Mt. Sinai School of Medicine). In our 
studies, these antibodies recognize cqib133, but not ctvl33 when expressed in 
K562  as assessed by flow cytometry and immunoprecipitation. The 131- 
reactive mAb P5D2 (8) was purchased from the Developmental Studies 
Hybridoma Bank (Iowa City, IA). mAb 9EG7 (31), which recognizes the 
high affinity state of 131 integrins was the kind gift of Dr. Dietmar Vestwe- 
ber, Max Planck Institute for Immunobiology. The HLA reactive mAb 
W6/32 (1) was purchased from the Amer. Type Culture Collection (Rock- 
ville, MD). The monoclonal antibody 4E3, reactive against the gp 55 (Tac) 
subunit of the IL2 receptor was purchased from Boehringer Mannheim 
Corp. (Indianapolis, IN). mAbs IGl14 against human an, B6H12 and 2D3 
against human integrin associated protein (IAP), 7G2 specific for human 
integrin 133, and 3F12 and 1C12 specific for human integrin av originated in 
this laboratory and were made as described (21). Fluorescein-labeled anti- 
bodies directed against rat  or mouse IgG were purchased from Sigma 
Chem. Co. All antibody used as inhibitor were as purified IgG at 5.0 ~g/ 
ml unless specified. 
cDNA Clones and Cell Transfection 
The human 135 integrin subunit cDNA was the gift of Dr. Sarah Bodary 
(Genentech, Inc., San Francisco, CA) (35). Human integrin av cDNA (33) 
was a gift of Dr. Joseph C. Loftus (Scripps Research Institute, La Jolla, 
CA). Human 133 integrin cDNA was the gift of Dr. Jeffrey Smith (Scripps 
Research Institute, La Jolla, CA).  Human attb cDNA (40) was the gift of 
Dr. Joel Bennett (University of Pennsylvania). For transfection, the 135 
and 133 cDNA were cloned into the stable expression vector pRc/RSV (In- 
vitrogen,  San  Diego,  CA)  (135) or  a  derivative  of pRc/RSV,  termed 
pIAP58, with the cloning sites HindIII and XbaI in reverse orientation, 
(133) (32). The av and allb cDNA's were subcloned into pCDM8 (Invitro- 
gen). K562 cells were cotransfected with either av and 133, anb and [3a, cry 
and 135, or etv and 133NT by electroporation at 200 V, 600 I~f using a Gene 
Pulser (Bio Rad Labs. Richmond, CA) cDNA encoding chimeras of the 
extracellular domain of the IL-2 receptor, gp 55, Tac subunit linked to the 
cytoplasmic tail domain of the 139 and 135 integrins (described in references 
29, 30) were cotransfected with a neomycin selectable marker from pRc/ 
RSV under the same transfection conditions. Transfected cell populations 
used in this study are KRc/RSV (vector alone), Kotv133 (ctv and 133), Karl35 
(av and 135), Kuub133 (~IIb and 139), Kotv133NT (uv and tailless 139 construct), 
KaM132 (aMacl and  132), KTac133 (IL2-133 chimera), KTac135 (IL2-135 chi- 
mera), and KTacNT  (IL2  tailless receptor construct). Transfected cells 
were selected in media containing 1,200 p.g/ml G418 (Genticin, Gibco), 
and populations of transfectants expressing high levels of the transfected 
integrin were obtained by fluorescence cell sorting. For selection of inte- 
grin chimera expressing clones, cells were subjected to limiting dilution 
cloning after transfection and high expressing clonal populations were se- 
lected by FACS analysis using antibody 4E3 (Boehringer Mannheim) di- 
rected against the gp 55 subunit of the IL-2 receptor. K562  transfected 
with cDNA encoding the ~4 subunit (Ko~4131) were kindly provided by Dr. 
Martin Hemler, Dana Farber Cancer Institute (34). 
FA  CS Analysis of Transfected and Endogenous 
Receptor Expression 
Receptor expression on macrophages and K562 cells was analyzed by flu- 
orescent flow cytometry as described (5, 32). Table I shows the relative ex- 
pression levels (mean channel fluorescence) of transfected and endoge- 
nous integrin receptors as assessed by the specific antibodies indicated 
and flow cytometry for cells used in these studies. For all cells used, the 
mean channel fluorescence of irrelevant, isotype-matched antibodies did 
not exceed 0.10. Expression of ct5131, demonstrated by mAb 16 and P5D2 
fluorescence, directed against ~5 and 131, respectively, remained at levels 
comparable to  untransfected K562  when additional integrins were ex- 
pressed. Also, as assessed by IC12, antibody specific for cry, the relative ex- 
pression of ~v133 and ~135 were equivalent in the transfectants expressing 
these respective integrins. 
Flow Cytometric Phagocytosis Assay 
Direct measurement of FITC-ligand opsonized particle phagocytosis by 
endogenous and transfected integrins in K562 cells was performed by flow 
cytometry as previously described (2) and expressed as a Phagocytic In- 
dex, the number of beads internalized per 100 cells (PI) (21). 
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Adhesion of transfected K562  cells  to ligand coated substrate was per- 
formed  as  described  (2).  Briefly,  96-well  microtiter  plates  (Dynatech, 
Chantilly,  VA)  were  coated  with  ligand  (fibronectin,  vitronectin,  or 
casein) at 50 wg/ml in PBS at 4°C for 6 h. Nonadherent protein was re- 
moved by washing three times with PBS and wells blocked by the addition 
of 1% BSA in PBS for 30 rain at room temperature. Cells were washed in 
HBSS, labeled with Calcein AM fluorescent dye (Molecular Probes, Eu- 
gene,  OR)  according  to  manufacturer's instructions and  suspended  in 
HBSS with 1.0 mM each of Ca  ++, Mg  ÷*, and Mn  ÷* and 0.5%  HSA. Cells 
were added to plates in 200 wl at 106/ml and incubated for 1.5 h at 37°C. 
Plates were rinsed twice gently with PBS and adhesion measured in a fluo- 
rescence plate reader (Cytofluor 2300, Millipore,  Marlborough, MA). In 
some studies Lysophosphatidic Acid (LPA, Sigma Chem. Co.) was added 
along with cells at 5.0 v,g/ml in PBS. Adhesion data is presented as percent 
of control (KRc\RSV) adhesion to fibronectin. 
Reagents 
H7 and HA-1004 were purchased from LC Laboratories (Woburn, MA). 
All other reagents were purchased from Sigma Chem. Co. 
Data Presentation 
Data are presented as either the mean -+ SEM or as a representative study 
from at  least  three  yielding  equivalent results.  Significance  was deter- 
mined by analysis of variance followed by Duncan's comparison testing.  A 
minimum confidence interval of 95 % was used in all analyses. 
Results 
Integrin Expression and Integrin-mediated Adhesion 
in Transfectants 
Stable K562 transfectants  expressing %133 (Ketv133), Otllb133 
(Kalib133),  et  v and the  tailless  133 subunit  (Kav133NT), Otv135 
(Ketv135), and a4131 (Kot4131) were used in these studies. Ex- 
pression of transfected receptors  as quantitated  by FACS 
is shown in Table I. Expression  of the  endogenous  K562 
integrin,  ets~31, was unaffected by transfection  of the addi- 
tional integrins (Table I). Adhesion of the various integrin 
transfectants  to  fibronectin  (Fn)-coated  surfaces  was 
equivalent  (Fig.  1  A).  KOqlb133, Kctv133, and  KOtv133NT at- 
tached equivalently to vitronectin (Vn)-coated surfaces; as 
expected,  the  other  transfectants  did  not  adhere  to  Vn, 
since they did not express a Vn receptor. 
attbfl3 Ligation Regulates asflt Phagocytosis 
Previous work showed that ligation of %133, but not etv135, 
inhibited et5131 phagocytosis. This suggested a requirement 
for 133 in the  signal transduction  event (2).  To determine 
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Figure 1. Adhesion of K562 cells expressing transfected integrins 
to ligands. K562 transfected with cDNAs encoding integrins, mu- 
tant integrins, or chimeric integrins were assessed for the ability 
to attach to fibronectin- (hatched bars), vitronectin- (open bars), 
or casein- (filled bars) coated substrate as described in Materials 
and Methods  in the absence (A) or presence (B) of 5.0  ~g/ml 
lysophosphatidic acid (LPA). Data are expressed as the percent 
of KRc/RSV  adhesion  to  fibronectin  in  the  absence  of LPA. 
Shown is a summary of three separate experiments. 
whether there was a  chain specificity as well for the signal- 
ing event, K562 cells were stably transfected with cDNAs 
encoding  the  aIIb133 receptor  (KCtlib133). The  expressed 
~IIb133 was  functional  in  binding  assays  (Fig.  2).  Unlike 
controls, including vector-transfected K562 (Fig. 2 A) and 
Table L Integrin Expression in Transfected K562 Cells 
P5D2  IC12  LM609  P1F6  IB4  IGII4  mAb 16  10E5 
(~1)  (~v)  (cwl33)  (cwl35)  (p2)  (~x4)  (c~5)  (c~Lro) 
KRc/RSV  9.83  0.21  0.19  0.17  0.26  0.32  14.8  0.31 
Kav133  10.1  25.2  27.8  0.22  0.31  ND  13.9  ND 
Kctv135  9.61  26.7  0.23  39.5  0.18  ND  14.1  ND 
Kedlbl~3  10.2  0.35  0.17  0.28  0.22  0.19  13.6  23.35 
Ket4[31  10.7  0.17  ND  ND  ND  34.2  12.5  ND 
KetMI32  11.3  0.21  ND  0.30  9.46  ND  14.1  ND 
Ketv133NT  9.66  31.2  28.8  0.17  ND  ND  14.1  ND 
Human macrophages  15.8  12.3  17.6  8.62  ND  11.2  15.8  ND 
Cultured human macrophages  and K562 ceils transfected with cDNA encoding various  integrin subunits  or mutant subunits  were prepared and assessed  for receptor expression  by 
flow cytometry as described in Materials and Methods. Reactivity of monoclonal antibodies is indicated in parentheses  below each antibody. Shown are the log mean channel 
(MCF) fluorescence  from a representative study. For each antibody, cells were stained in parallel, permitting  relative quantitation of receptor expression  between cell types for any 
specific antibody. The MCF for irrelevant isotype-matched  control antibodies did not exceed 0.10. 
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Figure 2. Phagocytosis of op- 
sonized  beads  by  transfected 
K562  cells.  K562  transfected 
with  vector  alone  (A)  or 
cDNAs encoding %133 (B),  O~  4 
(C),  or  cqib133 (D)  were  pre- 
sented with beads coated with 
the  indicated  opsonin  in  the 
presence  of monoclonal  anti- 
bodies  directed  against  inte- 
grin subunits,  and phagocyto- 
sis  was  assessed  by  flow 
cytometry as described in Ma- 
terials  and  Methods.  Mono- 
clonal antibody reactivities are 
indicated  in  parentheses  and 
the key for all graphs is shown 
in panel C.  Shown is a repre- 
sentative  study  of four  yield- 
ing identical results.  Data are 
presented  as a  Phagocytic In- 
dex as described  in Materials 
and Methods. 
Ket4131 (Fig. 2 C) and KetM[32 and K%[35 (2), KOqlb[33 bound 
and ingested  fibrinogen  (Fg)-opsonized  beads  (Fig.  2  D). 
Fg-mediated  phagocytosis  by these  cells  was  blocked  by 
both oqi  b- and  [33-specific mAb. Kotv[33 also bound  and in- 
gested  Fg-opsonized  beads,  and  this  was  blocked  by the 
[33-specific but  not  by the  cqib-specific mAb  10E5  (Fig.  2 
B). mAb 7E3, reactive against eqM33, has been reported to 
inhibit  %[33 function  in  platelets.  However,  this  Ab  does 
not react with Otv[33 expressed in K562 as assessed by flow 
cytometry or with human macrophages as assessed by im- 
munoprecipitation.  Additionally,  7E3  has  no  effect  on 
phagocytosis  in K562  expressing  tXvl33, but  does inhibit  in 
KOqib[33.  Thus  while  mAb  7E3  can  recognize  platelet  [33, 
the  recognition  epitope  is  unlikely  available  in  Ctv133 ex- 
pressed  on human  macrophages  or K562  cells.  As previ- 
ously  shown  for  Kotv[33 ,  KOqlb[33  phagocytosis  of  Fn- 
opsonized beads was partially inhibited  by mAb recogniz- 
ing  either  ot  5  or  [31  (not  shown).  Importantly,  for  both 
Kcxv[33  and  Koqlb[33  ,  mAb 7G2  to  [33 completely inhibited 
Fn  bead  phagocytosis  (Fig.  2,  B  and  D).  Anti-oqi b  10E5 
also blocked Fn bead phagocytosis  in the eqlb[33 transfec- 
tants. This complete inhibition did not occur upon ligation 
of transfected  receptors  in KtxM[32 or K%[35 (2)  or  Ko~4131 
(Fig.  2  C). Thus,  ligation of either  of two different  [33 re- 
ceptors  inhibited ots[31-mediated phagocytosis. 
The f13 Cytoplasmic Tail Is Required  for f13 Integrin 
Inhibition of a5  fl  I Phagocytosis 
To determine  the domain(s)  of [33 required  for regulation 
Figure 3. Effects of cytoplasmic 133 tail 
deletion  upon  ~tv133 regulation  of fi- 
bronectin bead phagocytosis. Phagocy- 
tosis of fibronectin-opsonized beads by 
KRc/RSV,  Kav133, and  Ko~v133NT was 
quantitated  by FACS,  in the presence 
of antibody against HLA class I  (W6/ 
32) or 133 (7G2). Shown is the summary 
of  four  experiments.  Data  are  pre- 
sented as a Phagocytic Index (PI). PI of 
casein opsonized beads by all cell types 
was less than 15 in all studies. 
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Figure 4. Expression of chimeric  integrins  in transfected K562. 
K562 were transfected with cDNA encoding chimeras of the In- 
terleukin 2 receptor tx subunit  extracellular  and transmembrane 
domains linked to the cytoplasmic domain of either [33 (KTac133), 
13s (KTac13s), or lacking a cytoplasmic tail (KTacNT) along with 
neomycin  selectable  vector  pRc/RSV  or  vector  alone  (KRc/ 
RSV).  Shown  is the  expression  of transfected chimeras as  as- 
sessed by flow cytometry using the IL2 receptor specific mono- 
clonal antibody 4E3 performed. Fluorescence  profile of an irrele- 
vant antibody was identical to 4E3 staining of KRc/RSV. 
of etst31-mediated  phagocytosis,  we  examined  KetvI33NT  , 
which express [33 truncated  at amino acid 728  and which 
therefore  lack  the  entire  [33  cytoplasmic  tail  after  the 
HDRRE sequence conserved in many integrin [3 cytoplas- 
mic tails. Although ligation of Otv[33 with the anti-[33 mAb 
7G2 completely blocked Fn-bead phagocytosis by Kctv[33, 
it had no effect on cts[31-mediated  ingestion in Kotv[33NT 
(Fig. 3). This indicates that the cytoplasmic tail of the [33 
subunit  is required  for the  signaling which  inhibits  ct5[~  1 
phagocytosis. 
The [33 Cytoplasmic Tail Is Sufficient for Inhibition of 
a5131 Phagocytosis 
To determine  if the  [33  tail  is  sufficient for signaling  to 
et5131, K562 cells were transfected with chimeric DNA con- 
structs encoding the extracellular and transmembrane do- 
mains of the  Interleukin 2  receptor small subunit  gp 55 
(Tac)  fused  with  the  cytoplasmic  tail  domains  of  [33 
(KTac[33)  or  [35  (KTac[35)  or  without  a  cytoplasmic tail 
(KTacNT). Expression of these constructs in stably trans- 
fected  K562  cells  was  approximately equivalent,  as  as- 
sessed by flow cytometry using antibody 4E3, specific for 
the Tac antigen (Fig. 4). Several studies have shown that 
expression of isolated integrin tail domains can disrupt ad- 
hesion of cells to substrate (30, 43). However, KTac[33 and 
KTac[35 both adhered equivalently to Fn-coated surfaces 
as KTacNT or the  control  K562 transfected with  vector 
alone  (Fig.  1 A).  Addition  of lysophosphatidic  acid  has 
been reported to uncover an inhibitory effect on adhesion 
of these autonomous integrin [~ chain cytoplasmic domain 
chimeras (43).  However, addition  of 5.0  p~g/ml lysophos- 
phatidic acid did not affect KTac[33 or KTac~5 adhesion to 
Fn (Fig. 1 B). Possibly, failure of these isolated [~ chain cy- 
toplasmic domains to inhibit adhesion reflects the fact that 
K562 adhesion to Fn is unassociated with cell spreading, 
and thus may not depend on the same integrin-cytoskele- 
tal associations as cells spreading on the Fn substrate. 
In contrast to their lack of effect on adhesion,  expres- 
sion of the autonomous [~3 cytoplasmic tail in K562 had a 
marked inhibitory effect on Fn-bead phagocytosis (Fig. 5). 
Expression of Tac[33, but not Tac[3s or TacNT decreased 
Fn-bead  phagocytosis to  the  background  level of casein 
bead phagocytosis. Surprisingly, inhibition by Tac[33 was 
reversed by the addition of the serine/threonine kinase in- 
hibitor H7, while the structurally related inhibitor HA1004 
had no effect (Fig. 6) (25). The Fn-bead phagocytosis seen 
in H7-treated KTac[33 was completely blocked by antibod- 
ies against oL5131 (data not shown). Together with the lack 
of effect of av[33NT on Fn-bead phagocytosis, these results 
demonstrate that the [33 cytoplasmic tail is both necessary 
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and sufficient for the inhibition of cx5131-mediated phagocy- 
tosis. Moreover, the data suggest that the inhibitory effect 
of expression of the autonomous 133 cytoplasmic tail results 
from constitutive activation of a kinase, rather than com- 
petition with endogenous [31 for a cytosolic protein. 
lAP Inhibition of a~[31 Phagocytosis Requires 
[33 Integrin 
IAP has been implicated in 133-dependent signal transduc- 
tion in leukocytes and endothelial cells (13, 41, 49). It has 
been hypothesized that IAP and Otv133  form a single signal 
transduction  complex,  but  evidence  in  favor  of that  hy- 
pothesis has been limited to studies with antibodies on pri- 
mary  cells  (49).  Although  K562  express  no  endogenous 
av133, they express  >105  copies/cell  of IAP  (not  shown). 
We examined the effect of IAP ligation on Fn-bead phago- 
cytosis in  the  K562  transfectants, using anti-IAP mAbs 
B6H12 and 2D3 (Fig. 7). B6H12 has been shown to be an 
inhibitory mAb in several assays, while 2D3  binds IAP 
with equal affinity, but is not inhibitory (6,42,49). Ligation 
of IAP by B6H12 inhibited ~x513rmediated Fn-bead phago- 
cytosis in Ko~v[33 and Kaiib133, but not in Kav135 or in K562 
transfected with the neo resistance vector alone (Fig. 7). 
As expected, 2D3 had no effect on et5131-mediated phago- 
cytosis in any transfectant. Inhibition by B6H12 was re- 
versed  by  the  addition  of H7  (data  not  shown).  Thus, 
B6H12 inhibition of as131-mediated ingestion required ex- 
pression of the 133 chain. Moreover, B6H12 had no effect 
on as131-mediated phagocytosis in the KOtv133NT cells (Fig. 
8),  demonstrating that the  inhibitory effect of anti-IAP 
mAb on asI31-mediated  phagocytosis required the 133 cyto- 
plasmic tail. 
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Figure  7.  IAP  can  regulate 
as[31  through  [33  integrins. 
Phagocytosis  of  fibronectin- 
opsonized  beads  by  KRc/ 
RSV, Kava3,  Karl3  5,  Kotiib~ 3 
in  the  presence  of  mono- 
clonal  antibodies  against 
HLA  Class  I  (W6/32, filled 
bars),  IAP  inhibitory 
epitope  (B6H12,  hatched 
bars),  or  IAP  noninhibitory 
epitope (2D3, open bars) was 
evaluated by FACS and are 
presented as a Phagocytic In- 
dex.  Shown is  the  summary 
of three experiments. PI for 
casein-opsonized  beads  was 
always  less  than  18  for  all 
transfectants, with or without 
antibodies. 
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avfl3 Inhibition of 015~  1 Phagocytosis Occurs Without a 
Change in a5~i Affinity for Ligand 
In  our  previous  study  we  demonstrated  that  Fn-bead 
phagocytosis in K562 required a  high  affinity conforma- 
tion of a513  t  which can bind soluble fibronectin (2). Ex- 
pression of Tac[33 in CHO cells has been shown to prevent 
aubl33 from achieving its high affinity conformation (10). 
Therefore, it was possible that the mechanism by which li- 
gation of av[33 inhibited a5131 phagocytosis involved pre- 
venting oL5~  1 from achieving the high affinity state, making 
it incapable of phagocytosis. We tested this hypothesis by 
two methods. First, we examined the binding of the mAb 
9EG7, which binds only to the high affinity state of [31 inte- 
grins (31), to K562 transfectants under conditions in which 
Fn-bead phagocytosis was supported or inhibited (Table 
II). Induction of the high affinity state of as[3t in Karl33 by 
addition of 2 mM Mn  2+ had no effect on the expression of 
the HLA class I molecule or the total number of as inte- 
grin on these cells. However, the addition of Mn  2+ greatly 
increased the 9EG7 binding,  demonstrating that at least 
Table II. Detection of High Affinity asfll Epitopes 
on K562 Transfectants 
Detecting Ab 
None  7G2 (anti-~3)  Stimulus 
Control  2.0 mM Mn  Control  2.0 mM Mn  Conditions 
W6/32 
(HLA)  13.7  12.9  12.8  13.1 
mAb 16 
(Total et5)  10.2  10.3  10.2  10.4 
9EG7 
(High Affinity et5)  0.47  22.1  0.45  21.6 
Kctv[}  3 were assessed for the expression of HLA class I, total ct  5 imegrin, and high af- 
fihity state cts[}  I by flow cytometry using monoclonal antibodies W6/32, mAb 16, and 
9EG7, respectively, under control conditions (HBSS,  1.0 mM Ca  ++, 1.0 mM Mg  ÷÷) or 
with the addition of 2.0 mM Mn  +- in the presence or absence of 7G2, monoclonal an- 
tibody reactive against ~3. Shown is the log of the mean channel fluorescence for a 
representative study. Staining was performed in parallel under all conditions and stim- 
uli to permit direct comparison between conditions for any one antibody. 
some a5131 had altered their conformation to the high af- 
finity state. Addition of the anti-J33 mAb 7G2 had no effect 
on 9EG7 epitope expression, which suggests that the affin- 
ity of a5131 is not changed upon ligation of av[~  3. To confirm 
that  av[33 ligation  affects a5131 phagocytosis  through  an 
event subsequent to ligand binding, we examined the phago- 
cytosis of mAb 16-opsonized beads by Kay[33.  mAb 16 is 
specific for the a5 subunit and its binding to Kay[33 is unaf- 
fected by Mn  2+ or by av[33 ligation. Therefore, binding of 
mAb16-coated beads to a5~t should be independent of the 
conformation of the receptor. Nonetheless, phagocytosis 
of mAb 16 was markedly inhibited in KTac[3  a compared to 
KTac[35 (Fig. 9 A), demonstrating that a5131 phagocytosis 
of this ligand also was inhibited by constitutive expression 
of the  [33 cytoplasmic tail.  Moreover, ligation of av[33 in 
Kav[33 with 7G2 abolished the phagocytosis of mAb 16 op- 
sonized  beads,  whereas  control  antibody  against  HLA 
(W6/32) had no effect (Fig. 9 B). Inhibition of phagocyto- 
sis of the mAb 16-coated beads by av[33 ligation or expres- 
sion of Tac[33 was reversed by the addition of H7 (data not 
shown).  These  data  demonstrate  that  [~3  inhibits  the 
phagocytic function of high affinity a5[~  1 receptors by in- 
terference with an event downstream from ligand binding. 
Discussion 
In addition to its role as an adhesive ligand in extracellular 
matrix,  fibronectin is  a  major opsonin in  human  serum 
which functions in both host defense and wound repair. 
While this aspect of Fn function has been known for many 
years, the molecular aspects of Fn's  role as  an opsonin, 
rather than as a conventional adhesion molecule, are not 
known. Among the reasons for this lack of understanding 
is the large number of different potential fibronectin re- 
ceptors on macrophages, the major effector cells in recog- 
nition of fibronectin-opsonized bacteria and debris. More- 
over,  several  different  experimental  approaches  have 
suggested that  there may be communication among the 
Fn-binding integrins expressed on phagocytic cells which 
further complicates analysis of the role for individual Fn 
receptors. 
To study the mechanisms involved in integrin crosstalk 
in the regulation of interaction with Fn, we have used a 
model of transfection of different integrins into K562 cells, 
Blystone et al. art3 Signal Transduction  751 175" 
x 
LU 
d3  15O- 
Z 
125- 
O 
I'--  100"  >- 
© 
0  75" 
(5 
<  50-  T 
O.. 
25- 
0 
KTac63  KTac65 
TRANSFECTANT 
CASEIN  m  FIBRONECTIN[--"~  mAb  16  (~5) 
2oo  f 
bl°° 1 
KRc/RSV  KRc/RSV  Kctv133  Kc~v133 
+W632  (HI_A)  ..r-7G2 (133)  +W632  (HLA)  +7G2  (83) 
TRANSFECTANT/TREATMENT 
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rentheses. 
which endogenously express only Ot5131. In our previous re- 
port (2) we showed that av[33 ligation differentially regu- 
lates  the  phagocytic and  adhesive properties  of o~5131 in 
K562 cells. While expression of ~v133 had no effect on ~s131 
function  as  an  adhesion  receptor, ligation  of ~v133 with 
ligand  or antibody completely blocked a5131 recognition 
and  phagocytosis of Fn-opsonized particles.  This  effect 
was specific for 0/-v133  ,  since neither av13S nor  OtM132 trans- 
fected into K562 modulated et5131 function at all. Because 
av133-mediated inhibition of et5131 phagocytosis could be re- 
versed by pharmacologic inhibitors of protein kinase C, we 
hypothesized that ~v133 ligation initiated a signal transduc- 
tion cascade which modulated e~5131 function. 
The current studies have extended this model of integrin 
crosstalk  to begin to understand  the initiation  of signal 
transduction  and the mechanism of inhibition.  We have 
shown that expression of the 133 cytoplasmic tail is neces- 
sary and sufficient for inhibition of as131-mediated  phago- 
cytosis. The data for this conclusion are (a) OqIb133 is equally 
effective at modulation of 0/-5131 phagocytosis as Otv133; (b) li- 
gation of Otv13aNT  , in which the 133 cytoplasmic tail has been 
truncated a few amino acids after the transmembrane do- 
main, has no effect on ct5131 function; and (c) the isolated 
133 cytoplasmic tail, expressed as a transmembrane protein 
with irrelevant transmembrane and extracellular domains, 
constitutively inhibits et5131 phagocytosis. This last effect is 
not reproduced by the 135 cytoplasmic tail, again suggesting 
specificity for 133 in the inhibition. Since the 133 cytoplasmic 
domain is only 47 amino acids and unlikely to have enzy- 
matic activity on its own, it is reasonable to speculate that 
there are cytosolic proteins in K562 cells which interact 
specifically with intracytoplasmic sequences in 133. 
Our data are reminiscent of studies which show that 131 
and/or 133 cytoplasmic tails can inhibit focal contact forma- 
tion, cell adhesion, and activation of the high affinity state 
of Otrib133 (10, 30,  43). These studies have been interpreted 
to demonstrate that these cytoplasmic tails  compete for 
cytoplasmic proteins which link integrins to the cytoskele- 
ton or to the integrin-activation complex. However, there 
are  important  differences  between  our  data  and  these 
studies.  First,  KTac133, which  have  no  ct513rmediated 
phagocytosis, adhere normally to Fn. This suggests  that 
the 133 cytoplasmic tail differentially regulates these func- 
tions of ~5131 in K562 cells. Second, the inhibitory effect of 
the 133 cytoplasmic tail is rapidly reversed by H7, a serine/ 
threonine kinase inhibitor, suggesting that 133 is not acting 
as a  simple competitive inhibitor of the et5131 integrin by 
binding a cytosolic protein which is necessary for phagocy- 
tosis and would otherwise bind to the ligated 131 integrin. 
The alternative hypothesis, that the isolated 133 cytoplas- 
mic tail constitutively activates a  signal transduction cas- 
cade which results in inhibition of ct5131 phagocytosis, but 
not adhesion, is more likely (30). 
The ability of the  133 cytoplasmic tail to initiate signal 
transduction was somewhat surprising because of previous 
experiments demonstrating an apparently central role for 
IAP  in  Otv133 signaling  (41).  Experiments  demonstrating 
that antibody to IAP could block 133-induced activation of 
phagocytes and 133-dependent  increase in [Ca2+]i  in endo- 
thelial cells suggested  that IAP would have an essential 
role in av133-initiated  signal  transduction.  Moreover, the 
complex structure  of IAP  suggested  that  it would  be  a 
good candidate for linking the integrin to signal transduc- 
tion cascades. To investigate the role of IAP, we tested the 
effect of anti-IAP mAb on ct5131 phagocytosis. In the ab- 
sence of ~v133, anti-IAP had no effect on  ot5131 function. 
This  is  genetic  evidence which  supports  the  hypothesis 
that 133 integrins and lAP form a single signaling complex. 
This signaling complex requires the 133 cytoplasmic tail, be- 
cause its removal in KC~v133NT  abolished the regulatory ef- 
fect of the anti-IAP mAb. This result, together with the 
fact that the Tac133 is constitutively active, suggests that 
IAP does not have an essential role in linking the integrin 
to intracellular signaling molecules. Instead, at least in this 
model, IAP appears to have an auxiliary role, perhaps by 
altering av133 conformation in a way that facilitates its acti- 
vation of the  signal  transduction  cascade.  Alternatively, 
intracytoplasmic sequences in IAP may interact with the 
133 cytoplasmic tail to initiate signal transduction. Unfortu- 
nately, we are unable to test whether IAP is essential for 
signal transduction by intact 133 integrins in this model, be- 
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of IAP. 
We previously demonstrated that phagocytosis  by et513t 
required activation  to the high affinity state  through the 
addition  of manganese  or  conformation  stabilizing  anti- 
bodies. Several investigators have demonstrated that a513t- 
mediated adhesion to fibronectin is mediated by the low 
affinity state  of the  integrin  (18).  Thus we hypothesized 
that  133 specifically inhibited  functions of ets~ 1 which re- 
quired its high affinity state. This suggested the possibility 
that 133-initiated signal transduction might inhibit the abil- 
ity of Ot5~ 1 to achieve high affinity for ligand. Tac[33 chime- 
ras have been shown to have precisely this effect on o~iib133 
transfected into CHO cells (10). However, we found that 
ligation  of etv133 had  no  effect  on  the  expression  of the 
epitope for 9EG7, a mAb which recognizes only the high 
affinity state  of 131 integrins  (31).  Second, we found that 
phagocytosis of beads opsonized with mAb 16, which rec- 
ognizes ot  5 equivalently  in both conformations of the re- 
ceptor, also was inhibited by ligation of av133. This inhibi- 
tion was reversed by the addition of H7 (data not shown), 
demonstrating  that  inhibition  of  phagocytosis  of  mAb- 
opsonized  beads  and  Fn-opsonized  beads  proceeded  by 
the  same  signaling  pathway.  Thus  we conclude  that  [33- 
dependent inhibition of ~5131  phagocytosis affects an event 
in phagocytosis subsequent to ligand recognition by ets[31. 
In summary, we have shown that there is "crosstalk" be- 
tween integrins etv133 and ot5131 in K562 cells and likely in 
human phagocytes (2). Ligation of the etv133/IAP complex 
activates a signal transduction cascade which inhibits phago- 
cytosis, but not adhesion, mediated by et5131. This integrin 
crosstalk requires the 133 cytoplasmic tail, and isolated 133 
cytoplasmic domain constitutively downregulates the phago- 
cytic function of e~5~  1. The crosstalk  is not bidirectional, 
since ligation of 0~5131 does not affect av133 phagocytic func- 
tion ([2] and data not shown). Although ~5131 phagocytosis 
requires the high affinity state of the integrin,  [33 regula- 
tion of phagocytosis is not via modulation of a5131 affinity 
for ligand. This suggests  that  133 cytoplasmic domain ini- 
tiates a signal transduction  cascade, potentially involving 
protein kinase C, which has as its target proteins involved 
in etsI31-mediated  phagocytosis.  While the  significance  of 
this signaling pathway for cellular responses to Fn is not 
yet known, it is likely to have an important effect on the 
phenotype  of  macrophages,  endothelial  cells,  platelets, 
and other cells expressing [33 integrins. Because these cell 
types are often involved in inflammation and repair, this 
pathway may be especially significant in host defense and 
wound healing. 
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